Summary: The research study explores the growing public interest in the off-label use of Glucagon-like Peptide 1 (GLP-1) agonists, particularly Ozempic, for cosmetic weight loss. Using Google Trends, the study reveals a significant surge in relative search volume (RSV) for “Ozempic”, “Wegovy”, and “Mounjaro” over a 5-year period, indicating a heightened curiosity and potential demand… Read More Cosmetic Use Of Ozempic On The Rise